Skip to main content

Table 2 Percentage of significant increase in markers levels at each time point of the chemotherapy treatment

From: Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients

Time points cTnT NT-proBNP sST2 miR-126-3p miR-199a-3p miR-423-5p miR-34a-5p
NA2 42% 58% 64% 76% 64% 78% 98%
D8 73% 60% 87% 78% 89%
3 M 47% 60% 69% 71% 73% 89%